Latest Articles
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report - Cureus
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report Cureus
Published: Sept. 25, 2026, 8:57 a.m.
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report - cureus.com
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report cureus.com
Published: Sept. 25, 2026, 8:57 a.m.
Absci (ABSI) Maps Out Phase 2 Trial, Is It Still 29% Undervalued? - simplywall.st
Absci (ABSI) Maps Out Phase 2 Trial, Is It Still 29% Undervalued? simplywall.st
Published: Sept. 24, 2026, 5:54 p.m.
U.S. Supreme Court turns down surrogate McKenna West’s request to intervene in custody case - Face2Face Africa
U.S. Supreme Court turns down surrogate McKenna West’s request to intervene in custody case Face2Face Africa
Published: Sept. 24, 2026, 2:30 p.m.
U.S. Supreme Court turns down surrogate McKenna West’s request to intervene in custody case - face2faceafrica.com
U.S. Supreme Court turns down surrogate McKenna West’s request to intervene in custody case face2faceafrica.com
Published: Sept. 24, 2026, 2:30 p.m.
Absci Corporation Announces Preliminary Details for Phase 2 Storyline? Trial of Ai-Designed Antibody Abs-201? for Endometriosis - marketscreener.com
Absci Corporation Announces Preliminary Details for Phase 2 Storyline? Trial of Ai-Designed Antibody Abs-201? for Endometriosis marketscreener.com
Published: Sept. 24, 2026, 1:52 p.m.
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 - Investing.com
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 Investing.com
Published: Sept. 24, 2026, 12:51 p.m.
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis - The Manila Times
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis The Manila Times
Published: Sept. 24, 2026, 12:10 p.m.
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis - manilatimes.net
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis manilatimes.net
Published: Sept. 24, 2026, 12:10 p.m.
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 - Investing.com UK
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 Investing.com UK
Published: Sept. 24, 2026, 12:06 p.m.
Link copied to clipboard!